Stock Detail
WATSON PHARMACEUTICALS INC
Drugs - Generic
WPI @ Yahoo Finance | WPI Option @ Yahoo Finance
Last Day's Data
| Current Price | High | Value Change | Percent Change | Dividend | Previous Close |
|---|---|---|---|---|---|
| $64.52 | $65.56 | $-1.31 | -1.99% | 0.00 | $65.83 |
| Opening Price | Low | Volume | Market Cap | Average Volume | P/E |
| $65.24 | $64.44 | 927,673 | 8.2B | 1.25M | 44.35 |
Pivot Table
| R2 | R1 | Pivot | S1 | S2 |
| 65.96 | 65.24 | 64.84 | 64.12 | 63.72 |
Stock Profile
Watson Pharmaceuticals, Inc. engages in the development, manufacture, marketing, distribution, and sale of branded and generic pharmaceutical products in the United States. It offers a range of generic products, such as antidepressants, anti-diabetics, analgesic, oral contraceptives, anti-hypertensives, anti-anxiety products, antibiotics, anti-infective systems, antihistamine products, and aid to smoking cessation. Watson Pharmaceuticals offers various branded pharmaceutical products that include specialty products, such as urology, anti-hypertensive, psychiatry, pain management, and dermatology products, as well as a genital warts treatment and a visual cervical screening device; and nephrology products, which consists of products for the treatment of iron deficiency anemia. The company sells its brand and generic pharmaceutical products primarily to drug wholesalers, retailers, and distributors, including large chain drug stores, hospitals, and clinics; government agencies; and managed healthcare providers, such as health maintenance organizations and other institutions. Watson Pharmaceuticals was founded in 1983 and is headquartered in Corona, California.